Solventum Corp (SOLV) stock
SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3089% above fair value
$86.48+0.42 (+0.49%)
Close on Nov 18, 2026Market cap $14.72BP/E 97.2Yield –
Solventum shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Solventum's shares outstanding was 171M at Sep 30, 2026. For fiscal 2025 it was 175M, up 0.9% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 175M | +0.9% |
| FY2024 | Dec 31, 2024 | 174M | +0.6% |
| FY2023 | Dec 31, 2023 | 173M | 0.0% |
| FY2022 | Dec 31, 2022 | 173M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 171M | -2.6% |
| Q2 FY2026 | Jun 30, 2026 | 173M | -1.1% |
| Q1 FY2026 | Mar 31, 2026 | 176M | +0.4% |
| Q4 FY2025 | Dec 31, 2025 | 176M | +0.7% |
| Q3 FY2025 | Sep 30, 2025 | 175M | +0.9% |
| Q2 FY2025 | Jun 30, 2025 | 175M | +1.0% |
| Q1 FY2025 | Mar 31, 2025 | 175M | +1.2% |
| Q4 FY2024 | Dec 31, 2024 | 175M | +1.1% |
| Q3 FY2024 | Sep 30, 2024 | 174M | +0.7% |
| Q2 FY2024 | Jun 30, 2024 | 174M | +0.5% |
| Q1 FY2024 | Mar 31, 2024 | 173M | 0.0% |
| Q4 FY2023 | Dec 31, 2023 | 173M | – |
| Q3 FY2023 | Sep 30, 2023 | 173M | – |
| Q2 FY2023 | Jun 30, 2023 | 173M | – |
| Q1 FY2023 | Mar 31, 2023 | 173M | – |
See a number that looks wrong?